LGALS9 and Sepsis: As reported in previous studies, LGALS9 (galectin‐9) exhibited a protective effect in polymicrobial sepsis,22 SIGLEC7 was an important negative regulator of acute inflammatory responses and was a potential target for the treatment of sepsis.23